ENSG vs. PACS, GMED, HQY, ACHC, PCVX, EXEL, ITCI, ELAN, JAZZ, and CYTK
Should you be buying The Ensign Group stock or one of its competitors? The main competitors of The Ensign Group include PACS Group (PACS), Globus Medical (GMED), HealthEquity (HQY), Acadia Healthcare (ACHC), Vaxcyte (PCVX), Exelixis (EXEL), Intra-Cellular Therapies (ITCI), Elanco Animal Health (ELAN), Jazz Pharmaceuticals (JAZZ), and Cytokinetics (CYTK). These companies are all part of the "medical" sector.
PACS Group (NYSE:PACS) and The Ensign Group (NASDAQ:ENSG) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership, community ranking and analyst recommendations.
The Ensign Group received 345 more outperform votes than PACS Group when rated by MarketBeat users. However, 100.00% of users gave PACS Group an outperform vote while only 66.10% of users gave The Ensign Group an outperform vote.
In the previous week, PACS Group had 13 more articles in the media than The Ensign Group. MarketBeat recorded 29 mentions for PACS Group and 16 mentions for The Ensign Group. PACS Group's average media sentiment score of 0.50 beat The Ensign Group's score of 0.45 indicating that The Ensign Group is being referred to more favorably in the news media.
96.1% of The Ensign Group shares are owned by institutional investors. 3.9% of The Ensign Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
The Ensign Group has higher revenue and earnings than PACS Group.
PACS Group presently has a consensus price target of $30.50, indicating a potential upside of 23.83%. The Ensign Group has a consensus price target of $124.60, indicating a potential upside of 6.52%. Given The Ensign Group's stronger consensus rating and higher possible upside, equities research analysts clearly believe PACS Group is more favorable than The Ensign Group.
The Ensign Group has a net margin of 5.67% compared to The Ensign Group's net margin of 0.00%. PACS Group's return on equity of 17.60% beat The Ensign Group's return on equity.
Summary
The Ensign Group beats PACS Group on 8 of the 13 factors compared between the two stocks.
Get The Ensign Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for ENSG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ENSG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
The Ensign Group Competitors List
Related Companies and Tools
